Home

Thursday, December 5, 2024 Thursday, December 12, 2024 Thursday, December 19, 2024 Credit Type CME,CNE,AAPA, AANP Intended Learners This activity is intended for primary care clinicians, including physicians, NPs, PAs, residents, fellows, RNs, and other members of the primary care team, as well as and other relevant physician specialties who may play a role in the management of migraine. In support o f improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing

Read the full article here

Source: hmp-global.swoogo.com

Categories: General News, General Medicine News

Tweets with this article

Consultant360

Join us for a free, interactive webinar designed to enhance migraine care in your primary care practice. With three convenient opportunities to attend, you'll gain actionable strategies to better diagnose and manage migraine in your patients. Learn more: https://t.co/60WRdfsfAc https://t.co/oqRs99vU29

Related Articles

The Impact of the EMBARK Trial on Treatment Decisions in High-Risk Biochemical Recurrent Prostate Cancer – Neal Shore

Zach Klaassen and Neal Shore discuss the outcomes of the EMBARK trial, focusing on treatment strategies for high-risk biochemically recurrent prostate cancer. In this detailed…

UroToday.com November 22, 2024

Sanofi plans to change payment terms for 340B hospitals

Sanofi is the third company – along with J&J and Eli Lilly – to attempt to change the way it pays for medicines under the…

pharmalot November 22, 2024

FDA Roundup: November 22, 2024

FDA Roundup: November 22, 2024

U.S. FDA November 22, 2024

Overcoming Hormone Resistance: ARV-766 in Advanced Prostate Cancer – Daniel Petrylak

David Crawford discusses with Daniel Petrylak a new approach to treating advanced prostate cancer using a PROTAC agent called ARV-766. Dr. Petrylak explains that PROTACs…

UroToday.com November 22, 2024

Payers Are Putting Profit Over Patients with Denials and Prior Auth Policies, Hospitals Say – MedCity News

Hospitals are facing increasingly burdensome policies from commercial insurers, leading to problems with cash flow and patient safety. Hospital executives think federal regulators need to…

MedCity News November 22, 2024

Advancing Treatment for High-Risk Biochemical Recurrence Prostate Cancer: The ARASTEP Trial – Alexander Chehrazi-Raffle

Zach Klaassen discusses the ARASTEP trial with Alex Chehrazi-Raffle. The trial focuses on patients with high-risk biochemical recurrence of prostate cancer, specifically those who show…

UroToday.com November 22, 2024

FGFR3 Inhibition for Upper Tract Urothelial Cancer: Phase 1b Trial Results – Surena Matin

Sam Chang interviews Surena Matin about a phase 1b trial evaluating FGFR3 inhibition in localized upper tract urothelial carcinoma (UTUC). Dr. Matin discusses the study’s…

UroToday.com November 22, 2024

US CDC confirms H5N1 bird flu in a child in California

The U.S. Centers for Disease Control and Prevention (CDC) said on Friday it has confirmed a human infection with H5N1 bird flu in a child…

Reuters Health November 22, 2024

A new device for delivering drugs without needles draws inspiration from the elegant squid

Proof-of-concept experiments show the device is more efficient than other methods of delivering drugs orally, and more convenient than needles.

STAT November 22, 2024

Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with

pharmalot November 22, 2024